IL33 and diabetic kidney disease: It has been shown that the IL-33/ST2 signaling pathway is activated in diabetic nephropathy (Elsherbiny et al., 2020), and endothelial dysfunction can be induced during the development of diabetic nephropathy (Xue et al., 2020).